Marlow, UK – 12 January 2021 – Tetris Pharma, a specialty pharmaceutical company distributing niche hospital and injectable prescription products across Europe, today announces the appointments of Phil Walker as COO, Maddy Kennedy as CFO, Mike Withe as Commercial Head of Europe, and Matt Kennedy as Director of Supply Chain.
Tetris’s new COO, Phil Walker, joins the company with circa 20 years’ Finance, Strategy & Operations experience within large multinational, transitional midsize and early-stage companies, including GSK, LEO Pharma and Unilever. Phil brings strong experience of leading finance and supply chain activities for pharmaceutical product roll outs across the UK and Northern European markets. Phil is CIMA qualified with an Executive MBA from London Business School.
Maddy Kennedy, who has worked with Tetris since mid-2021, has over 20 years’ experience as a CFO in both public and private companies, largely in life science and SME entrepreneurial businesses. Maddy has a background of supporting long-term business growth whilst maintaining financial stability, and a proven track record in M&A, fundraising, IPO activity and investor relations. Recently, Maddy has worked with Arquer Diagnostics Ltd, MyHealthChecked plc, Ieso Digital Health Ltd and Psioxus Therapeutics Ltd. Prior to that she was CFO for Lab21 Ltd and Finance Director at Alliance Pharma plc from start-up through to the IPO on AIM. She is also NED for Nuformix plc.
Mike Withe, who joins the Tetris team as Commercial Head of Europe, has over 30 years of pharma experience, building teams and leading successful European product launches within the Specialty and Orphan drugs marketplace. He has a track record of achievement working with globally recognised brands including having been Head of Rare Diseases for Chiesi and, most recently, created the commercial infrastructure for Diurnal, which delivered two successful European Endocrinology product launches.
Matt Kennedy has over 20 years’ supply chain management experience, leading European supply set-up and integration for both start-up and larger pharmaceutical companies, including Shire, Archimedes and Clinigen. Joining Tetris as Director of Supply Chain, Matt brings a wealth of experience in new product launches, market expansion, serialisation, storage and distribution, and supply chain governance.
Commenting on the appointments, Dr Shafiq Choudhary, CEO of Tetris, said: “We are pleased to welcome Phil, Maddy, Mike and Matt to strengthen our rapidly expanding team. Their experience and expertise will be invaluable as we work to grow our development, commercialisation and distribution platform to deliver niche prescription products throughout Europe. They join the Company at an opportune time as we approach a key milestone for our lead product to treat severe episodes of hypoglycaemia for people living with diabetes.”
Tetris’s growing pipeline currently includes 10 license and supply agreements with large pharma. The Company plans to add two-to-three new in-licensed or acquired products per year.